Loews Corp Has Lifted Its Aetna INC (AET) Stake by $27.00 Million; Stock Value Declined

April 22, 2018 - By Graig Alexander

Aetna Inc. (NYSE:AET) LogoInvestors sentiment decreased to 0.83 in Q4 2017. Its down 0.08, from 0.91 in 2017Q3. It dropped, as 69 investors sold AET shares while 345 reduced holdings. 147 funds opened positions while 198 raised stakes. 275.71 million shares or 1.91% less from 281.08 million shares in 2017Q3 were reported. Everence Management has invested 0.3% in Aetna Inc. (NYSE:AET). Berkshire Asset Management Limited Liability Com Pa has invested 0.07% in Aetna Inc. (NYSE:AET). Ww Asset holds 0.17% of its portfolio in Aetna Inc. (NYSE:AET) for 28,657 shares. Old Mutual Customised Solutions (Proprietary) Ltd holds 0.12% in Aetna Inc. (NYSE:AET) or 6,703 shares. Envestnet Asset Mgmt holds 0.01% or 28,303 shares in its portfolio. Cornerstone Capital Hldgs Ltd Com owns 69,319 shares or 0.09% of their US portfolio. Private Ocean Limited Liability holds 0.01% in Aetna Inc. (NYSE:AET) or 71 shares. Louisiana State Employees Retirement Sys owns 19,700 shares. Geode Cap Management Ltd Co holds 3.34M shares or 0.2% of its portfolio. 287 are owned by Vigilant Capital Limited. Reilly Fincl Advisors Limited Liability Company accumulated 1.64% or 63,879 shares. Sio Management Llc has invested 5.91% in Aetna Inc. (NYSE:AET). Neuberger Berman Limited Liability Company has invested 0.44% in Aetna Inc. (NYSE:AET). Chicago Equity Prtn Llc reported 0.18% of its portfolio in Aetna Inc. (NYSE:AET). Comm Fincl Bank invested in 0.04% or 18,544 shares.

Loews Corp increased its stake in Aetna Inc (AET) by 2678.57% based on its latest 2017Q4 regulatory filing with the SEC. Loews Corp bought 150,000 shares as the company’s stock declined 6.45% with the market. The institutional investor held 155,600 shares of the medical specialities company at the end of 2017Q4, valued at $28.07 million, up from 5,600 at the end of the previous reported quarter. Loews Corp who had been investing in Aetna Inc for a number of months, seems to be bullish on the $57.88 billion market cap company. The stock increased 0.28% or $0.49 during the last trading session, reaching $176.92. About 1.67M shares traded. Aetna Inc. (NYSE:AET) has risen 33.34% since April 22, 2017 and is uptrending. It has outperformed by 21.79% the S&P500.

Loews Corp, which manages about $16.53B US Long portfolio, decreased its stake in Anthem Inc (NYSE:ANTM) by 23,500 shares to 17,100 shares, valued at $3.85 million in 2017Q4, according to the filing. It also reduced its holding in Axalta Coating Systems Ltd by 195,000 shares in the quarter, leaving it with 250,000 shares, and cut its stake in Goldcorp Inc (NYSE:GG).

Aetna Inc. (NYSE:AET) Ratings Coverage

Among 14 analysts covering Aetna Inc (NYSE:AET), 7 have Buy rating, 0 Sell and 7 Hold. Therefore 50% are positive. Aetna Inc has $212.0 highest and $170.0 lowest target. $197.08’s average target is 11.39% above currents $176.92 stock price. Aetna Inc had 24 analyst reports since October 23, 2017 according to SRatingsIntel. The firm earned “Hold” rating on Monday, October 23 by Piper Jaffray. The stock has “Hold” rating by Argus Research on Wednesday, December 6. The rating was maintained by Piper Jaffray with “Buy” on Tuesday, January 30. On Wednesday, December 20 the stock rating was downgraded by Morgan Stanley to “Equal-Weight”. Credit Suisse maintained the shares of AET in report on Wednesday, January 31 with “Hold” rating. Wells Fargo maintained Aetna Inc. (NYSE:AET) on Monday, December 18 with “Buy” rating. Cantor Fitzgerald maintained the shares of AET in report on Monday, October 23 with “Buy” rating. Cantor Fitzgerald maintained the stock with “Hold” rating in Tuesday, January 30 report. The stock has “Neutral” rating by Cantor Fitzgerald on Friday, October 27. Citigroup maintained it with “Buy” rating and $197 target in Thursday, November 2 report.

Aetna Inc. (NYSE:AET) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.